#CancerTreatment Archives - Page 2 of 2

🩸🇨🇳💡Current status of diagnosis and treatment of chronic lymphocytic leukemia in China: A national multicenter survey research

By Mourabit Halima 2024.01.18

Professor Jun Ma and his team from Harbin Institute of Hematology Oncology published in May 2023 in the Chinese Journal of Hematology titled "Current status of diagnosis and treatment of…

ESMO Hot Review | Prof. Ying Fan: DB-04 Study Shows Survival Benefit and Sustained Efficacy of T-DXd Treatment

By Lisa Cui 2024.01.17

Editor's Note: The mid-term analysis results of the DESTINY-Breast04 (DB-04) study were striking, quickly influencing international guidelines such as NCCN and ESMO, and obtaining approvals for indications related to HER2…

ESMO Expert Commentary | Dr. Yao Zhu: Success or Failure Does Not Define a Hero, Numerous Prostate Cancer Studies Aid in Optimizing Patient Survival

By Mourabit Halima 2024.01.17

Editor's Note: Prostate cancer is the leading male urological tumor in China and has become one of the fastest-growing male malignancies in the past decade. The recent ESMO conference unveiled…

The Cure Puzzle: Key Factors in Curing Metastatic Sarcoma Explored with Professor Silvia Stacchiotti

By El Bachir MOURABIT 2024.01.13

Engaging in a critical discussion on the topic of "When can we cure patients with metastatic sarcoma?" Professor Silvia Stacchiotti provided invaluable insights during an exclusive interview with Oncology Frontier…

Revolutionizing Cancer Treatment: Unveiling TAR-200 with Professor Andrea Nccchi

By Mourabit Halima 2024.01.13

In a captivating interview conducted on-site at the European Society for Medical Oncology (ESMO), Oncology Frontier had the privilege of engaging with Professor Andrea Nccchi to unravel the mysteries behind…

Dr. Huiqiang Huang: Combining PD-1 Monoclonal Antibody and HDAC Inhibitor with Conventional P-Gemox Significantly Improves the Treatment Outcome for NK/T Cell Lymphoma

By Mourabit Halima 2024.01.11

Editor's Note: From June 17th to 23rd, 2023, the 17th International Conference on Malignant Lymphoma (ICML) was held grandly in Lugano, Switzerland. As the world's largest conference on malignant lymphoma,…

#CancerTreatment

🩸🇨🇳💡Current status of diagnosis and treatment of chronic lymphocytic leukemia in China: A national multicenter survey research

ESMO Hot Review | Prof. Ying Fan: DB-04 Study Shows Survival Benefit and Sustained Efficacy of T-DXd Treatment

ESMO Expert Commentary | Dr. Yao Zhu: Success or Failure Does Not Define a Hero, Numerous Prostate Cancer Studies Aid in Optimizing Patient Survival

The Cure Puzzle: Key Factors in Curing Metastatic Sarcoma Explored with Professor Silvia Stacchiotti

Revolutionizing Cancer Treatment: Unveiling TAR-200 with Professor Andrea Nccchi

Dr. Huiqiang Huang: Combining PD-1 Monoclonal Antibody and HDAC Inhibitor with Conventional P-Gemox Significantly Improves the Treatment Outcome for NK/T Cell Lymphoma

Strategy First! UCLI-ICML Joint Session Lays Foundation for Collaboration

🔬 Navigating Advanced Prostate Cancer: A Deep Dive with Dr. Silke Gillessen

CCHIO International Vision丨Dr. Dorothy Mary Keefe: Current status of cancer prevention and treatment in Australia